Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (22.600)

51

Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens : patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial

enthalten in: The Lancet. Haematology | 2024

von Delforge, M. | Patel, K. | Eliason, L. | +15

ErratumIn: Lancet Haematol. 2024 Mar 12;:. - PMID 38490233

52

Post hoc analysis of patients with rheumatoid arthritis under clinical remission in two Japanese Phase 3 trials of peficitinib treatment (RAJ3 and RAJ4)

enthalten in: Modern rheumatology | 2024

von Tanaka, Y. | Takeuchi, T. | Morita, Y. | +3

53

Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease : A subgroup analysis of a global, randomised, controlled Phase 3 trial

enthalten in: Modern rheumatology | 2024

von Kuwana, M. | Takehara, K. | Tanaka, Y. | +4

54

Reply of the Authors : Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

enthalten in: Fertility and sterility | 2024

von Nelson, S. | Fauser, B. | García-Velasco, J. | +2

55

Long-term efficacy and safety of romiplostim in refractory aplastic anemia : follow-up of a phase 2/3 study

enthalten in: Blood advances | 2024

von Mitani, K. | Lee, J. | Jang, J. | +20

56

Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol : a multicentre randomised controlled trial

enthalten in: Anaesthesia | 2024

von Fechner, J. | El-Boghdadly, K. | Spahn, D. | +15

57

A post hoc analysis of previously untreated patients with severe hemophilia A who developed inhibitors in the PUPs A-LONG trial

enthalten in: Blood advances | 2024

von Carcao, M. | Schiavulli, M. | Kulkarni, R. | +5

58

Guselkumab provides durable improvement across psoriatic arthritis disease domains : post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

enthalten in: RMD open | 2024

von Coates, L. | Gossec, L. | Zimmermann, M. | +8

59

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Ten Ham, R. | Rohaan, M. | Jedema, I. | +13

60

Long-term treatment with lasmiditan in patients with migraine : post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial

enthalten in: The journal of headache and pain | 2024

von Komori, M. | Ozeki, A. | Tanji, Y. | +6